OncoSec Medical Incorporated Quarterly report pursuant to Section 13 or 15(d)

Quarterly report pursuant to Section 13 or 15(d)

Stock-Based Compensation (Details Narrative)

Stock-Based Compensation (Details Narrative) - USD ($)					1 Months Ended			3 Months Ended		6 Months Ended
Stock-Based Compensation (Details Narrative) - USD ($)	Oct. 29, 2018	Oct. 26, 2018	Oct. 23, 2018	Aug. 22, 2018	Jan. 31, 2019	Dec. 31, 2018	Oct. 31, 2018	Jan. 31, 2019	Jan. 31, 2018	Jan. 31, 2019	Jan. 31, 2018
Purchase price of incentive stock options as a percentage of its fair value										85.00%
Number of stock options cancelled										1,943,118
Options granted to purchase shares										2,616,000
Term of stock options										1 year 7 months 2 days
Exercise price										$ 0.86
Shares available for grant					974,128			974,128		974,128
Intrinsic value of options outstanding					$ 425,000			$ 425,000		$ 425,000
Intrinsic value of options exercisable					41,000			41,000		41,000
Unrecognized stock-based compensation expenses					$ 3,000,000			$ 3,000,000		$ 3,000,000
Weighted-average grant date fair value of stock options granted								$ 0.46	$ 1.37	$ 0.57	$ 1.29
Research And Development Expense [Member]
Stock-based compensation costs								$ 250,000	$ 200,000	$ 1,100,000	$ 400,000
General And Administrative Expense [Member]
Stock-based compensation costs								850,000	2,100,000	1,800,000	2,300,000
Restricted Stock Units (RSUs) [Member]
Stock-based compensation costs								$ 200,000	200,000	$ 400,000	$ 300,000
Options granted to purchase shares							50,000
Exercise price							$ 1.64
Number of granted shares vested	12,500	25,000					37,500
Number of shares vesting percentage		25.00%
Number of shares vesting, description		The Company's Board of Directors approved the accelerated vesting of 25% of the outstanding restricted stock units (RSUs) held by the employee. The RSUs, which originally vest on the third anniversary of the grant date, or March 29, 2020, were accelerated to vest on October 26, 2018.
Modification of accrued expense on unvested stock units		$ 63,278
Fair value of vested stock grants		$ 44,250
Number of restricted stock outstanding					1,138,541			1,138,541		1,138,541
Restricted Stock Units (RSUs) [Member] \| October 29, 2019 [Member]
Number of granted shares vested					12,500
Restricted Stock Units (RSUs) [Member] \| October 29, 2020 [Member]
Number of granted shares vested					12,500
Restricted Stock Units (RSUs) [Member] \| October 29, 2021 [Member]
Number of granted shares vested					12,500
Maximum [Member]
Maturity										6 years 6 months	6 years 6 months
Minimum [Member]
Maturity										5 years	5 years
Individual [Member] \| Stock Option Cancellation Agreements [Member]
Number of stock options cancelled				300,000
Number of restricted stock issued				175,000
Stock-based compensation costs				$ 135,425
Two Consultants [Member] \| Stock Option Cancellation Agreements [Member]
Number of stock options cancelled			535,000
Stock-based compensation costs			$ 377,278
Employees [Member]
Options granted to purchase shares										200,000
Term of stock options										10 years
Vesting period of stock options granted										3 years
Exercise price										$ 1.64
Consultants [Member]
Stock-based compensation costs								$ 205,788	$ 734,250	$ 449,348	$ 843,250
Options granted to purchase shares										500,000
Term of stock options										10 years
Number of shares issued for service								143,000	375,000	327,000	475,000
Number of shares issued for service, value								$ 229,190	$ 734,250	$ 480,750	$ 843,250
Consultants [Member] \| Maximum [Member]
Exercise price										$ 1.43
Consultants [Member] \| Minimum [Member]
Exercise price										$ 0.8461
Mr. Daniel J. O'Connor [Member] \| Restricted Stock Units (RSUs) [Member]
Options granted to purchase shares						750,000
Exercise price						$ 0.6001
Number of granted shares vested						62,500
Number of shares vesting, description						The units vest as follows: 62,500 units vested on January 31, 2019, and the remaining 687,500 units vest in equal quarterly installments of 62,500 units beginning on April 30, 2019 and ending on October 31, 2021.
Number of unit remaining available to vest						687,500
Mr. Daniel J. O'Connor [Member] \| Equal Quarterly Installments [Member] \| Restricted Stock Units (RSUs) [Member]
Number of unit remaining available to vest						62,500
Employees, Directors and Consultants [Member]
Stock-based compensation costs								$ 1,100,000	$ 2,300,000	$ 2,900,000	$ 2,700,000
2011 Plan [Member]
Number of shares authorized for issuance to awards granted					1,000,000			1,000,000		1,000,000
Provisional percentage of outstanding stock owned by stockholders										10.00%
2011 Plan [Member] \| Minimum [Member]
Purchase price of incentive stock options as a percentage of its fair value										100.00%
Exercise price as a percentage of fair value of common stock										110.00%
2011 Plan [Member] \| Common Stock [Member]
Number of shares authorized for issuance to awards granted					9,500,000			9,500,000		9,500,000
2011 Plan [Member] \| Common Stock [Member] \| Maximum [Member]
Maximum shares granted per fiscal year per individual										500,000
Stock option exercisable period										10 years
2011 Plan [Member] \| Employees, Directors and Consultants [Member]
Employee stock purchase program description										The 2011 Plan authorizes a total of 7,500,000 for issuance thereunder, and includes an automatic increase of the number of shares of common stock reserved thereunder on the first business day of each calendar year by the lesser of: (i) 3% of the shares of the Company's common stock outstanding as of the last day of the immediately preceding calendar year; (ii) 1,000,000 shares; or (iii) such lesser number of shares as determined by the Company's Board of Directors.
Number of shares authorized for issuance to awards granted					7,500,000			7,500,000		7,500,000
Percentage of shares of common stock outstanding					3.00%			3.00%		3.00%
2011 Plan [Member] \| Employees [Member]
Options granted to purchase shares										1,241,000	933,500
Term of stock options										10 years	10 years
Vesting period of stock options granted										3 years	3 years
2011 Plan [Member] \| Employees [Member] \| Maximum [Member]
Exercise price										$ 1.58	$ 1.32
2011 Plan [Member] \| Employees [Member] \| Minimum [Member]
Exercise price										$ 0.6001	$ 0.92
2011 Plan [Member] \| Directors [Member]
Options granted to purchase shares										675,000	450,000
Term of stock options										10 years	10 years
Vesting period of stock options granted											1 year
2011 Plan [Member] \| Directors [Member] \| Maximum [Member]
Vesting period of stock options granted										3 years
Exercise price										$ 0.8412	$ 1.94
2011 Plan [Member] \| Directors [Member] \| Minimum [Member]
Vesting period of stock options granted										1 year
Exercise price										$ 0.655	$ 0.979
2011 Plan [Member] \| Consultants [Member]
Options granted to purchase shares											125,000
Term of stock options											10 years
2011 Plan [Member] \| Consultants [Member] \| Maximum [Member]
Exercise price											$ 1.32
2011 Plan [Member] \| Consultants [Member] \| Minimum [Member]
Exercise price											$ 1.00
2011 Plan [Member] \| Mr. Daniel J. O'Connor [Member]
Options granted to purchase shares											2,500,000
Vesting period of stock options granted											2 years
Number of granted shares vested											1,000,000
2011 Plan [Member] \| Mr. Daniel J. O'Connor [Member] \| Performance Stock Option Award [Member]
Options granted to purchase shares											250,000
2011 Plan [Member] \| Mr. Daniel J. O'Connor [Member] \| Tranche One [Member]
Options granted to purchase shares											1,000,000
2011 Plan [Member] \| Mr. Daniel J. O'Connor [Member] \| Tranche Two [Member] \| Performance Stock Option Award [Member]
Options granted to purchase shares											500,000
2011 Plan [Member] \| Mr. Daniel J. O'Connor [Member] \| Tranche Three [Member]
Options granted to purchase shares											250,000
ESPP [Member]
Number of shares authorized for issuance to awards granted					500,000			500,000		500,000
Stock-based compensation costs										$ 6,500	$ 7,000
Shares available for grant					396,616			396,616		396,616
Discount from market price, offering date										15.00%
Fair market value of unvested shares, percentage										15.00%
Maturity										6 months	6 months
Risk free interest rate										2.22%	1.15%
Volatility rate										61.83%	62.60%
Forfeitures percentage										0.00%	0.00%
Dividend										$ 0	$ 0
ESPP [Member] \| Six Month Call On The Unvested Share [Member]
Purchase price of incentive stock options as a percentage of its fair value										85.00%
ESPP [Member] \| July 31, 2016 [Member] \| First Offering Period [Member]
Shares purchased										17,789
ESPP [Member] \| January 31, 2017 [Member] \| Second Offering Period [Member]
Shares purchased										18,631
ESPP [Member] \| July 31, 2017 [Member] \| Third Offering Period [Member]
Shares purchased										21,646
ESPP [Member] \| January 31, 2018 [Member] \| Fourth Offering Period [Member]
Shares purchased										18,960
ESPP [Member] \| July 31, 2018 [Member] \| Fifth Offering Period [Member]
Shares purchased										12,071